What is BioBeats?
BioBeats is at the forefront of enhancing mental wellbeing through a scientifically validated mobile application and wearable device. The company specializes in collecting biometric and psychometric health data to improve employee mental health, reduce absenteeism, and deliver personalized health insights. BioBeats prioritizes data privacy, offering organizations real-time aggregated health data for informed decision-making regarding employee wellbeing. Their dedicated in-house clinical research team drives continuous development and assessment of their solutions, ultimately aiming to foster happier lives for employees.
How much funding has BioBeats raised?
BioBeats has raised a total of $4.6M across 3 funding rounds:
Angel/Seed
$650K
Private Equity
$2.3M
Other Financing Round
$1.7M
Angel/Seed (2013): $650K with participation from ZhenFund, ENIAC Ventures, and Cantora Records
Private Equity (2016): $2.3M led by IQ Capital, AXA Strategic Ventures, and White Cloud Capital
Other Financing Round (2018): $1.7M supported by IQ Capital and Oxford Sciences Innovation
Key Investors in BioBeats
IQ Capital
IQ Capital is a venture capital firm investing in 'deep-tech' across sectors including machine learning, AI, and data-focused propositions. They focus on companies capable of global market dominance and invest from seed to Series A stages.
AXA Strategic Ventures
AXA Strategic Ventures is the venture capital fund backed by AXA, investing globally in enterprise software, fintech, consumer technologies, and digital health.
White Cloud Capital
White Cloud Capital engages in strategic venture capital investment, focusing on fast-growing companies and high-potential investments within its portfolio.
What's next for BioBeats?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for BioBeats. This capital infusion is expected to fuel further innovation in their data-driven mental wellbeing solutions, potentially expanding their market reach and enhancing their technological capabilities. The company's focus on deep-tech, AI, and data-centric propositions, as evidenced by its backers, suggests a strategic direction towards scaling its platform and solidifying its position as a leader in corporate wellness technology.
See full BioBeats company page
